Search

Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease

Trial N/A Recruiting May 12, 2026

Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's Disease

Trial Phase 3 Completed May 12, 2026

A Study to Evaluate the Efficacy and Safety of Monosialotetrahexosylganglioside Sodium Injection in Parkinson's Disease Participants With Motor Fluctuations

Trial Phase 2 Not yet recruiting May 12, 2026

Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD

Trial Phase 2 Active, not recruiting May 12, 2026

North American Prodromal Synucleinopathy Consortium Stage 2

Trial N/A Enrolling by invitation May 12, 2026

EMG of Gait Under Dual-Task in Parkinson Desease

Trial N/A Completed May 12, 2026

Exoskeleton-Assisted Mobility in Aging and in Parkinson's Disease

Trial N/A Recruiting May 12, 2026

Dopamine 2 receptor ablation from cholinergic neurons attenuates L-DOPA induced dyskinesias.

Research Frontiers in aging neuroscience May 12, 2026

Friend or foe? Glial-vascular interactions in health and neurodegenerative disease.

Research Pharmacological reviews May 12, 2026

Parkinson's through a cultural lens: Diversity in disease expression and care

News SAGE Publications: Journal of Parkinson’s Disease: Table of Contents May 11, 2026

AID-FOG: Artificial Intelligence-Driven Freezing of Gait Detection in the Home

Trial N/A Recruiting May 11, 2026

C-STAR Movement Database

Trial N/A Active, not recruiting May 11, 2026

PET Imaging in Parkinson Disease Dementia

Trial N/A Active, not recruiting May 11, 2026

New Clinical Rehabilitation Approach for the Management of Falls Risks

Trial N/A Completed May 11, 2026

Personality and Quality of Life Amelioration After Continuous Subcutaneous Apomorphine Infusion in Parkinson's Disease

Trial N/A Completed May 11, 2026

Genetic Testing by Age at Onset in Parkinson Disease.

Research JAMA neurology May 11, 2026

Distinct Sympathoneural and Cardiovagal Domains of Arterial Baroreflex Function in Autonomic Synucleinopathies.

Research Research square May 11, 2026

This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.

Trial Phase 1 Recruiting May 10, 2026

Pain in Parkinson's Disease: Exploration of the Serotonin System in Positron Emission Tomography (PET [18F]-MPPF)

Trial N/A Recruiting May 10, 2026

Prevention of Medical, Social, and Psychosocial Risks Following a Parkinson's Disease Diagnosis: A Pilot Study

Trial N/A Not yet recruiting May 10, 2026